Telix Pharmaceuticals Ltd
For the period ended Dec 31, 2025. Filed Feb 20, 2026.
View on SEC.govAbout this filing
The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.
FY2025 · Filed Feb 20, 2026
TLX$9.63+2.2%Stored close · as of Nov 6, 2026
Contents
ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS
A. Directors and Senior Management
B. Advisers
C. Auditors
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.